. 2016 Aug;57(4):398–401. doi: 10.3325/cmj.2016.57.398

Table 1.

Proposals for the declaration of interest and how to improve transparency whether a conflict of interest might exist

Targets	The economic interests of clinicians and researchers need to be more transparent
	• Establish sustainable trust and confidence in clinical science, medical practice, and data published from physicians and scientists • Enable patients’, audiences’, or readers’ own judgments as to whether a conflict of interest impacts science or practice

Proposals	How to improve transparency
	1. The conflict of interest should be declared  a. on the first slide of any oral presentation and  b. on the last line of the abstract as in all New England Journal of Medicine papers (3) 2. For the sake of confidence, the dominant conflict of interest should be declared first (1). 3. Consider mentioning funding by industry also in the patient information form of any investigator-initiated trial. 4. Avoid employees of a company influencing the conduct of a trial and the presentation of data (27,28). It should be part of the primary contract that all contributions by employees or representatives of industry can only be mentioned in the acknowledgment (29).

Proposals

How to improve transparency

1. The conflict of interest should be declared  a. on the first slide of any oral presentation and  b. on the last line of the abstract as in all New England Journal of Medicine papers (3) 2. For the sake of confidence, the dominant conflict of interest should be declared first (1). 3. Consider mentioning funding by industry also in the patient information form of any investigator-initiated trial. 4. Avoid employees of a company influencing the conduct of a trial and the presentation of data (27,28). It should be part of the primary contract that all contributions by employees or representatives of industry can only be mentioned in the acknowledgment (29).